Venus Remedies Ltd. Financials

15:59 May 30

Venus Remedies Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
435.20
+29.85 (+7.36%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Venus Remedies Ltd. Financials

Venus Remedies Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
435.20
+29.85 (+7.36%)
15:59 May 30
Quality
image/svg+xml

68/100
High Financial Strength

Valuation
image/svg+xml

77/100
Affordable Valuation

Technical

61/100
Technically Moderately Bullish

Strength

17

Weakness

2

Opportunity

1

Threats

0

8.07 %

ROE %

6.33 %

ROA %

33.92

EPS

419.56

BVPS

6.99 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
548.12 598.65 555.51 601.45 647.89
Operating Expenses +
494.34 536.54 495.31 541.86 584.35
Raw Material
347.94 381.97 322.95 357.35 373.81
Increase Decrease in Cost
-7.15 3.48 8.04 -2.66 4.81
Other Manufacturing Expense
11.16 12.78 14.37 18.5 0
Employee Cost
46.02 52.33 61.33 71.5 80.49
Miscellaneous Expenses
96.37 85.98 98.94 123.31 175.32
Operating Profit
53.78 62.11 60.2 59.59 63.54
Other Income
19.63 8.31 10.32 11.58 20.96
Depreciation
35.28 33.53 32.3 26.44 22.51
Interest
13.02 0.48 0.29 0.09 0.07
Profit before tax and exceptio..
25.11 36.41 37.93 44.64 61.92
Exceptional Items
23.44 0 0 0 9.91
PBT
48.55 36.41 37.93 44.64 71.83
Provision for Taxation
-13.21 -4.32 11.36 16.15 26.51
Net Profit
61.77 40.72 26.57 28.49 45.32
NET Profit after MI
61.77 40.72 26.57 28.49 45.32
EPS
50.04 30.86 19.88 21.31 33.9
Operating Profit Margin (%)
9.81 10.38 10.84 9.91 9.81
Net Profit Margin (%)
11.27 6.8 4.78 4.74 7

Venus Remedies Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 41.80 41.80 41.80 41.80 41.80
FII 1.30 1.10 1.20 1.10 1.50
MF 0.00 0.00 0.00 0.00 0.00
Public 56.90 57.10 56.90 57.00 56.60
Others 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.10 0.10 0.10
Shareholder Shares Holding %
Download Our App On: